Dosimetry
Showing 51 - 75 of 1,002
Refractory Solid Tumor Trial in Xiamen (177Lu-DOTA-EB-FAPI radionuclide therapy)
Recruiting
- Refractory Solid Tumor
- 177Lu-DOTA-EB-FAPI radionuclide therapy
-
Xiamen, Fujian, ChinaThe First Affiliated Hospital of Xiamen University
Jul 26, 2023
Clear Cell Renal Cell Carcinoma, Suspected Recurrent Renal Clear Cell Carcinoma, Recurrent Renal Cell Cancer Trial
Not yet recruiting
- Clear Cell Renal Cell Carcinoma
- +2 more
- (no location specified)
May 14, 2023
Prostate Cancer, Adenocarcinoma of the Prostate Trial in Baltimore (Brachytherapy)
Active, not recruiting
- Prostate Cancer
- Adenocarcinoma of the Prostate
- Brachytherapy
-
Baltimore, MarylandThe SKCCC at Johns Hopkins
Nov 4, 2021
Dosimetry Trial in Vandoeuvre/les/nancy (Single Photon Emission Computed Tomography/ Computed Tomography (SPECT/CT))
Recruiting
- Dosimetry
- Single Photon Emission Computed Tomography/ Computed Tomography (SPECT/CT)
-
Vandoeuvre/les/nancy, FranceChru Nancy
Aug 3, 2021
Metastatic Prostate Cancer Trial in Perth (177Lu-DOTA-TLX591)
Not yet recruiting
- Metastatic Prostate Cancer
- 177Lu-DOTA-TLX591
-
Perth, Western Australia, Australia
- +1 more
Nov 25, 2021
Healthy Volunteers Trial in Edegem (99mTc-Duramycin)
Completed
- Healthy Volunteers
-
Edegem, Antwerpen, BelgiumUniversity Hospital Antwerp
Jan 12, 2022
Endometrial Cancer, Brachytherapy, Quality of Life Trial in New Haven (Tapered applicator, Standard applicator)
Recruiting
- Endometrial Cancer
- +2 more
- Tapered applicator
- Standard applicator
-
New Haven, ConnecticutSmilow Cancer Hospital
Sep 19, 2022
Breast Cancer, Radiation-Induced Vascular Disease, Left Anterior Descending Coronary Artery Stenosis Trial (Respiratory gating)
Not yet recruiting
- Breast Cancer
- +6 more
- Respiratory gating
- (no location specified)
Feb 3, 2023
Neuroendocrine Tumors Trial in New York (177Lu-DOTA-EB-TATE, Amino Acid Solution)
Recruiting
- Neuroendocrine Tumors
- 177Lu-DOTA-EB-TATE
- Amino Acid Solution
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jul 22, 2022
Bladder Cancer Trial in Saint Herblain (89Zr-TLX250 PET/CT)
Recruiting
- Bladder Cancer
- 89Zr-TLX250 PET/CT
-
Saint Herblain, FranceInstitut de cancerologie de l'Ouest
Nov 24, 2021
Glioblastoma Multiforme, Brain Tumors, Gastroesophageal Adenocarcinoma Trial in Lyon Cedex (68Ga-FF58)
Recruiting
- Glioblastoma Multiforme
- +3 more
-
Lyon Cedex, FranceNovartis Investigative Site
Aug 9, 2022
Lung Cancer Trial in Boston (Tc99m-MAA)
Recruiting
- Lung Cancer
- Tc99m-MAA
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Sep 10, 2021
Glioma, Malignant Trial in London (PET-MRI, Brain tumour biopsy)
Not yet recruiting
- Glioma, Malignant
- PET-MRI
- Brain tumour biopsy
-
London, United KingdomKing's College London
Jun 8, 2022
Sun Exposure Trial in Chirongui, Saint-Pierre (training on the risks associated with sun exposure)
Not yet recruiting
- Sun Exposure
- training on the risks associated with sun exposure
-
Chirongui, Mayotte
- +1 more
Apr 19, 2022
Exposure, Radiation Trial in Vandoeuvre-les-Nancy (Training in the use of the automaton)
Not yet recruiting
- Exposure, Radiation
- Training in the use of the automaton
-
Vandoeuvre-les-Nancy, FranceCHRU Nancy - Brabois
Aug 4, 2021
Sun Exposure Trial in Chirongui, Saint-Pierre (training on the risks associated with sun exposure, dosimetry)
Not yet recruiting
- Sun Exposure
- training on the risks associated with sun exposure
- dosimetry
-
Chirongui, Mayotte
- +1 more
Apr 4, 2022
Prostate Cancer, Metastatic Castration-resistant Prostate Cancer, mCRPC Trial in Glen Burnie (177Lu-rhPSMA-10.1 injection,
Recruiting
- Prostate Cancer
- +5 more
- 177Lu-rhPSMA-10.1 injection
- 18F-rhPSMA-7.3 injection
-
Glen Burnie, Maryland
- +3 more
Feb 2, 2023
Coronary Artery Disease (CAD), Myocardial Ischemia Trial in Beijing (XTR004)
Completed
- Coronary Artery Disease (CAD)
- Myocardial Ischemia
- XTR004
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Jan 23, 2022
Parkinson Disease, Dementia With Lewy Bodies, MSA - Multiple System Atrophy Trial in Leuven, Gent ([18F]-MFBG PET CT,
Not yet recruiting
- Parkinson Disease
- +3 more
- [18F]-MFBG PET CT
- +3 more
-
Leuven, Vlaams-Brabant, Belgium
- +1 more
Oct 31, 2023
Metastatic Castration-resistant Prostate Cancer Trial in Beijing (1.1 GBq (30 mCi) of 177Lu-P17-087, 1.1 GBq (30 mCi) of
Not yet recruiting
- Metastatic Castration-resistant Prostate Cancer
- 1.1 GBq (30 mCi) of 177Lu-P17-087
- 1.1 GBq (30 mCi) of 177Lu-P17-088
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Oct 30, 2022
Metastatic Castration-resistant Prostate Cancer Trial in Beijing (1.11 GBq (30 mCi) of 177Lu-PSMA-EB-01, 1.85 GBq (50 mCi) of
Recruiting
- Metastatic Castration-resistant Prostate Cancer
- 1.11 GBq (30 mCi) of 177Lu-PSMA-EB-01
- +2 more
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Nov 6, 2022
Gastroenteropancreatic Neuroendocrine Tumors, Pheochromocytoma, Paraganglioma Trial in Worldwide (Lutetium [177Lu]
Recruiting
- Gastroenteropancreatic Neuroendocrine Tumors
- +2 more
- Lutetium [177Lu] oxodotreotide/dotatate
-
Iowa City, Iowa
- +16 more
Apr 6, 2022
Systemic Amyloidosis Trial in Knoxville (99mTc-p5+14 is an amyloid reactive peptide labeled with technetium-99m.,
Recruiting
- Systemic Amyloidosis
- 99mTc-p5+14 is an amyloid reactive peptide labeled with technetium-99m.
- 99mTc-Pyrophosphate and 99mtc-p5+14 - an Amyloid Reactive Peptide Labeled With Technetium-99m.
-
Knoxville, TennesseeUniversity of Tennessee Graduate School of Medicine
Jul 10, 2023
Patients With CNS Diseases Trial in Beijing ((S)-[18F]FBFP PET/CT)
Recruiting
- Patients With Central Nervous System Diseases
- (S)-[18F]FBFP PET/CT
-
Beijing, ChinaPeking Union Medical College Hospital
Apr 13, 2022
Breast Cancer Trial in Fort de France (Radiotherapy by Prone and decubitus)
Terminated
- Breast Cancer
- Radiotherapy by Prone and decubitus
-
Fort de France, MartiniqueCHU de Martinique
Feb 21, 2022